These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 29027637)

  • 1. Vaccine adjuvants: smart components to boost the immune system.
    Bastola R; Noh G; Keum T; Bashyal S; Seo JE; Choi J; Oh Y; Cho Y; Lee S
    Arch Pharm Res; 2017 Nov; 40(11):1238-1248. PubMed ID: 29027637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Overview of the Types of Adjuvants Used in the Vaccination Industry And Their Mechanisms of Action.
    Shams N; Jaydari A; Najafi H; Hataminejad M; Khanizadeh S; Pouladi I
    Viral Immunol; 2024 Sep; 37(7):324-336. PubMed ID: 39172659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine adjuvants.
    Macy DW
    Semin Vet Med Surg Small Anim; 1997 Aug; 12(3):206-11. PubMed ID: 9283246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding modern-day vaccines: what you need to know.
    Vetter V; Denizer G; Friedland LR; Krishnan J; Shapiro M
    Ann Med; 2018 Mar; 50(2):110-120. PubMed ID: 29172780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled delivery of antigens and adjuvants in vaccine development.
    Zhao Z; Leong KW
    J Pharm Sci; 1996 Dec; 85(12):1261-70. PubMed ID: 8961136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel vaccines and adjuvant systems: the utility of animal models for predicting immunogenicity in humans.
    Davis HL
    Hum Vaccin; 2008; 4(3):246-50. PubMed ID: 18382138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvants for veterinary vaccines--types and modes of action.
    Gerdts V
    Berl Munch Tierarztl Wochenschr; 2015; 128(11-12):456-63. PubMed ID: 26697712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine Adjuvants: Selection Criteria, Mechanism of Action Associated with Immune Responses and Future Directions.
    Habib A; Anjum KM; Iqbal R; Jaffar G; Ashraf Z; Khalid MS; Taj MU; Zainab SW; Umair M; Zohaib M; Khalid T
    Iran J Immunol; 2023 Mar; 20(1):1-15. PubMed ID: 36917475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate endogenous adjuvants prime to desirable immune responses via mucosal routes.
    Wang X; Meng D
    Protein Cell; 2015 Mar; 6(3):170-84. PubMed ID: 25503634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond antigens and adjuvants: formulating future vaccines.
    Moyer TJ; Zmolek AC; Irvine DJ
    J Clin Invest; 2016 Mar; 126(3):799-808. PubMed ID: 26928033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Adjuvants and Immunomodulators for Veterinary Vaccines.
    Heegaard PM; Fang Y; Jungersen G
    Methods Mol Biol; 2016; 1349():63-82. PubMed ID: 26458830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights in mucosal vaccine development.
    Pavot V; Rochereau N; Genin C; Verrier B; Paul S
    Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvants: Classification, Modus Operandi, and Licensing.
    Apostólico Jde S; Lunardelli VA; Coirada FC; Boscardin SB; Rosa DS
    J Immunol Res; 2016; 2016():1459394. PubMed ID: 27274998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle vaccines.
    Zhao L; Seth A; Wibowo N; Zhao CX; Mitter N; Yu C; Middelberg AP
    Vaccine; 2014 Jan; 32(3):327-37. PubMed ID: 24295808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines.
    Moyle PM
    Biotechnol Adv; 2017; 35(3):375-389. PubMed ID: 28288861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of adjuvants: the future of vaccine design.
    Mount A; Koernig S; Silva A; Drane D; Maraskovsky E; Morelli AB
    Expert Rev Vaccines; 2013 Jul; 12(7):733-46. PubMed ID: 23885819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine Ingredients: Components that Influence Vaccine Efficacy.
    Kocourkova A; Honegr J; Kuca K; Danova J
    Mini Rev Med Chem; 2017; 17(5):451-466. PubMed ID: 27488583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The path to a successful vaccine adjuvant--'the long and winding road'.
    O'Hagan DT; De Gregorio E
    Drug Discov Today; 2009 Jun; 14(11-12):541-51. PubMed ID: 19508916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.